Sundyota Numandis Probioceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.41 Cr
as on 24-10-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 128.92 Cr
as on 24-10-2024
- Satisfied Charges ₹ 9.83 Cr
as on 24-10-2024
- Revenue 13.82%
(FY 2023)
- Profit 22.41%
(FY 2023)
- Ebitda 27.34%
(FY 2023)
- Net Worth 25.49%
(FY 2023)
- Total Assets 27.03%
(FY 2023)
About Sundyota Numandis Probioceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.41 Cr.
The company currently has active open charges totaling ₹128.92 Cr. The company has closed loans amounting to ₹9.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Arora, Bimal Trivedi, and Ketul Shah serve as directors at the Company.
- CIN/LLPIN
U24230GJ2011PTC067414
- Company No.
067414
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sundyota Numandis Probioceuticals Private Limited offer?
Sundyota Numandis Probioceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Diabetes, Sugar Substitutes, Health Conditions, Stomach Care.
Who are the key members and board of directors at Sundyota Numandis Probioceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimal Trivedi  | Director | 11-Oct-2011 | Current |
| Dinesh Arora | Director | 11-Oct-2011 | Current |
| Ketul Shah | Director | 19-Nov-2012 | Current |
Financial Performance of Sundyota Numandis Probioceuticals.
Sundyota Numandis Probioceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.82% increase. The company also saw a substantial improvement in profitability, with a 22.41% increase in profit. The company's net worth Soared by an impressive increase of 25.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundyota Numandis Probioceuticals?
In 2023, Sundyota Numandis Probioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sundyota Numandis Pharmaceuticals Private LimitedActive 21 years 6 monthsDinesh Arora is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Feb 2019 | ₹59.59 Cr | Open |
State Bank Of India Creation Date: 25 Jan 2019 | ₹52.17 Cr | Open |
State Bank Of India Creation Date: 25 Jan 2019 | ₹17.16 Cr | Open |
How Many Employees Work at Sundyota Numandis Probioceuticals?
Sundyota Numandis Probioceuticals has a workforce of 175 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundyota Numandis Probioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundyota Numandis Probioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
